All Stories

  1. A New Model of Chronic Mycobacterium abscessus Lung Infection in Immunocompetent Mice
  2. On the valid publication of names of mycobacteria
  3. Same meat, different gravy: ignore the new names of mycobacteria
  4. Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009–2016
  5. Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries
  6. Treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
  7. The new phylogeny of the genus Mycobacterium : The old and the news
  8. The new bacterial species description: the genus Mycobacterium as an example*
  9. Mycobacterium persicum sp. nov., a novel species closely related to Mycobacterium kansasii and Mycobacterium gastri
  10. Evolution of Phenotypic and Molecular Drug Susceptibility Testing
  11. Molecular typing of Mycobacterium Abscessus isolated from cystic fibrosis patients
  12. Use of WGS in Mycobacterium tuberculosis routine diagnosis
  13. Transmissibility and clinical significance of Mycobacterium abscessus in patients with cystic fibrosis
  14. Two cases of sternal osteomyelitis due to Mycobacterium africanum: a casual or causal association
  15. Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens
  16. The new phylogenesis of the genus Mycobacterium
  17. High prevalence of clustered tuberculosis cases in Peruvian migrants in Florence, Italy
  18. Characterization of 17 strains belonging to the Mycobacterium simiae complex and description of Mycobacterium paraense sp. nov.
  19. Mycobacterium celeriflavum sp. nov., a rapidly growing scotochromogenic bacterium isolated from clinical specimens
  20. Whole-Genome Sequence of Mycobacterium kyorinense
  21. Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium
  22. Mycobacterium abscessus Hand‐and‐Foot Disease in Children: Rare or Emerging Disease?
  23. Proposal of reclassification of Mycobacterium celatum type 2 as Mycobacterium kyorinense
  24. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
  25. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis
  26. Inventory study of non-tuberculous mycobacteria in the European Union
  27. Clinical peculiarities of tuberculosis
  28. Mycobacterium yongonensein Pulmonary Disease, Italy
  29. Mycobacterium iranicumInfection in HIV-infected Patient, Iran
  30. A Case of Mild Pulmonary Disease Due to Mycobacterium shimoidei with a Favorable Outcome
  31. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
  32. Disseminated Mycobacterium genavense infection after immunosuppressive therapy shows underlying new composite heterozygous mutations of β1 subunit of IL-12 receptor gene
  33. Mycobacterium fragae sp. nov., a non-chromogenic species isolated from human respiratory specimens
  34. Isolation of a Novel Strain of Mycobacterium iranicum from a Woman in the United States
  35. Epidemiology of cervico-facial pediatric lymphadenitis as a result of nontuberculous mycobacteria
  36. Isolation and identification of mycobacteria from captive reptiles
  37. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
  38. Drug-resistant tuberculosis among foreign-born persons in Italy: Table 1–
  39. Mycobacterium iranicum sp. nov., a rapidly growing scotochromogenic species isolated from clinical specimens on three different continents
  40. Characterization of a novel variant of Mycobacterium chimaera
  41. Is Real-Time PCR Better than Conventional PCR for Mycobacterium tuberculosis Complex Detection in Clinical Samples?
  42. Phylogeny of the genus Mycobacterium: Many doubts, few certainties
  43. Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy: Figure 1–
  44. Survey of 150 strains belonging to the Mycobacterium terrae complex and description of Mycobacterium engbaekii sp. nov., Mycobacterium heraklionense sp. nov. and Mycobacterium longobardum sp. nov.
  45. GenoType MTBDRslperformance on clinical samples with diverse genetic background
  46. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
  47. Mycobacterium shigaense sp. nov., a novel slowly growing scotochromogenic mycobacterium that produced nodules in an erythroderma patient with severe cellular immunodeficiency and a history of Hodgkin’s disease
  48. Research Priorities for HIV/M. tuberculosis Co-Infection
  49. Delayed Diagnosis of Disseminated Mycobacterium genavense Infection in a Human Immunodeficiency Virus-Negative Young Woman
  50. The use of microbead-based spoligotyping for Mycobacterium tuberculosis complex to evaluate the quality of the conventional method: Providing guidelines for Quality Assurance when working on membranes
  51. Research Priorities for HIV/M. tuberculosis Co-Infection
  52. Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay
  53. Detection and Molecular Characterization of Mycobacterium celatum as a Cause of Splenitis in a Domestic Ferret (Mustela putorius furo)
  54. Genetic diversity of human isolates of Mycobacterium bovis assessed by spoligotyping and Variable Number Tandem Repeat genotyping
  55. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
  56. Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiological approach
  57. Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobact...
  58. Standard operating procedure for optimal identification of mycobacteria using 16S rRNA gene sequences
  59. Mycobacterium europaeum sp. nov., a scotochromogenic species related to the Mycobacterium simiae complex
  60. Infection due to a novel mycobacterium, mimicking multidrug-resistant Mycobacterium tuberculosis
  61. Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species
  62. Disseminated Mycobacterium scrofulaceum infection in a child with interferon-γ receptor 1 deficiency
  63. UnusualMethylobacterium fujisawaenseInfection in a Patient withAcute LeukaemiaUndergoing Hematopoietic Stem Cell Transplantation: First Case Report
  64. Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiology approach
  65. Commercial DNA Probes for Mycobacteria Incorrectly Identify a Number of Less Frequently Encountered Species
  66. Clinical manifestations of nontuberculous mycobacteria infections
  67. In house colorimetric reverse hybridisation assay for detection of the mutation most frequently associated with resistance to isoniazid in Mycobacterium tuberculosis
  68. Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic species
  69. Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov.
  70. Characterization of Mycobacteria from a Major Brazilian Outbreak Suggests that Revision of the Taxonomic Status of Members of the Mycobacterium chelonae-M. abscessus Group Is Needed
  71. Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease
  72. Mycobacterium insubricum sp. nov.
  73. Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay
  74. Pulmonary Disease Due to Mycobacterium arosiense, an Easily Misidentified Pathogenic Novel Mycobacterium
  75. Use of the BacT/Alert MB Mycobacterial Blood Culture System for Detection of Mycobacteria in Sterile Body Fluids Other than Blood
  76. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
  77. Mycobacterium arosiense sp. nov., a slowly growing, scotochromogenic species causing osteomyelitis in an immunocompromised child
  78. LethalMycobacterium massilienseSepsis, Italy
  79. Variation of the expression ofMycobacterium tuberculosis ppe44gene among clinical isolates
  80. Mycobacterium alsiense, a Novel, Slowly Growing Species Isolated from Two Patients with Pulmonary Disease
  81. The first case of Mycobacterium sherrisii disseminated infection in a child with AIDS
  82. Three-Year Longitudinal Study of Genotypes of Mycobacterium tuberculosis Isolates in Tuscany, Italy
  83. Mycobacterium sherrisii isolation from a patient with pulmonary disease
  84. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility
  85. The new mycobacteria: an update
  86. Mycobacterium monacense sp. nov.
  87. Molecular Analysis of Clinical Isolates of Mycobacterium bovis Recovered from Humans in Italy
  88. Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant
  89. Mycobacterium lentiflavum, an emerging pathogen?
  90. Mutations in mutT genes of Mycobacterium tuberculosis isolates of Beijing genotype
  91. Ulcera del Buruli: la "nuova lebbra" Africana. Isolamento e identificazione di M. ulcerans in prelievi bioptici provenienti da pazienti del Benin
  92. Evaluation of the New GenoType Mycobacterium Assay for Identification of Mycobacterial Species
  93. Successfully treated spondylodiscitis due to a previously unreported mycobacterium
  94. Infections Due to the Newly Described Species Mycobacterium parascrofulaceum
  95. Mycobacterium florentinum sp. nov., isolated from humans
  96. Genetic Diversity, Determined on the Basis of katG463 and gyrA95 Polymorphisms, Spoligotyping, and IS6110 Typing, of Mycobacterium tuberculosis Complex Isolates from Italy
  97. A Case-Control Study for Multidrug-Resistant Tuberculosis: Risk Factors in Four European Countries
  98. Mycobacterium lentiflavumInfection in Immunocompetent Patient
  99. Taxonomic and phylogenetic status of non-tuberculous mycobacteria in a Caribbean setting
  100. Mycobacterial testing in hospital laboratories: results from a questionnaire survey in Italy
  101. Isolation of a novel sequevar of Mycobacterium flavescens from the synovial fluid of an AIDS patient
  102. Evaluation of Moxifloxacin ActivityIn VitroAgainstMycobacterium tuberculosis, Including Resistant and Multidrug-Resistant Strains
  103. Clinical features of infections caused by new nontuberculous mycobacteria, Part II
  104. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov.
  105. Mycobacterium parmense sp. nov.
  106. LINEE GUIDA E REQUISITI MINIMI PER I LABORATORI DI RIFERIMENTO A LIVELLO REGIONALE E NAZIONALE
  107. SENSIBILITÀ AI FARMACI DEL MICOBATTERIO TUBERCOLARE: APPROCCIO GENOTIPICO CON L’IMPIEGO DI MICROCHIP
  108. Clinical features of infections caused by new nontuberculous mycobacteria, part I
  109. Beijing/WMycobacterium tuberculosisin Italy
  110. First case of Mycobacterium haemophilum infection in an AIDS patient in Italy**
  111. A real-time PCR assay for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates
  112. Latin Grammar Headaches
  113. Evaluation of INNO-LiPA MYCOBACTERIA v2: Improved Reverse Hybridization Multiple DNA Probe Assay for Mycobacterial Identification
  114. Evaluation of a rapid immunochromatographic test for the serologic diagnosis of tuberculosis in Italy
  115. Mycobacterium elephantis : Not an Exceptional Finding in Clinical Specimens
  116. Evaluation of the BDProbeTec ET System for Direct Detection of Mycobacterium tuberculosis in Pulmonary and Extrapulmonary Samples: a Multicenter Study
  117. Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s
  118. Mycobacteria
  119. Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000
  120. Mycobacterium palustre sp. nov., a potentially pathogenic, slowly growing mycobacterium isolated from clinical and veterinary specimens and from Finnish stream waters.
  121. Mycobacterium palustre sp. nov., a potentially pathogenic, slowly growing mycobacterium isolated from clinical and veterinary specimens and from Finnish stream waters
  122. Identification of Mycobacteria by Using INNO LiPA
  123. Pseudoepidemic from Mycobacterium gordonae due to a contaminated automatic bronchoscope washing machine
  124. Human Infections Due to Mycobacterium lentiflavum
  125. Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of Proportion
  126. Mycobacterium doricum sp. nov
  127. Burden of Unidentifiable Mycobacteria in a Reference Laboratory
  128. Identification of 54 Mycobacterial Species by PCR-Restriction Fragment Length Polymorphism Analysis of the hsp65 Gene
  129. Performance Assessment of New Multiplex Probe Assay for Identification of Mycobacteria
  130. Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach
  131. Characterization of Mycobacterium bohemicum Isolated from Human, Veterinary, and Environmental Sources
  132. Bactericidal activity of moxifloxacin against pneumococci
  133. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems
  134. Unusual high-performance liquid chromatography profile of a strain of Mycobacterium avium
  135. Disseminated Mycobacterium terrae Infection in a Patient with Advanced Human Immunodeficiency Virus Disease
  136. Cervical Lymphadenitis Due to Mycobacterium bohemicum
  137. Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov
  138. Mycobacterium tusciae sp. nov.
  139. Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples2
  140. Multicenter evaluation of two commercial amplification kits (Amplicor, Roche and LCx, Abbott) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens
  141. HPLC does not differentiate Mycobacterium paratuberculosis from Mycobacterium avium
  142. Primary tuberculosis of the penis
  143. Primary tuberculosis of the penis
  144. Activity of 16 Antimicrobial Agents Against Drug-Resistant Strains ofMycobacterium tuberculosis
  145. Pulmonary infection due to <I>Mycobacterium szulgai</I>, case report and review of the literature
  146. Characterization of an Isolate Belonging to the Newly Described Species Mycobacterium hassiacum
  147. Inteins in mycobacterial GyrA are a taxonomic character
  148. EMPIRIC APPROACH USING CEPHALOSPORINS IN VENTILATOR ASSOCIATED PNEUMONIA (VAP)
  149. Multicenter evaluation of mycobacteria growth indicator tube (MGIT) compared with the BACTEC radiometric method, BBL biphasic growth medium and Löwenstein—Jensen medium
  150. Cervical lymphadenitis due to an unusual mycobacterium
  151. Isolation of Mycobacterium celatum from Patients Infected with Human Immunodeficiency Virus
  152. High-performance liquid chromatography and identification of mycobacteria
  153. Characterization of an Isolate of the Newly Described Species Mycobacterium interiectum
  154. Identification of the newly described Mycobacterium poriferae from tuberculous lesions of snakehead fish (Channa striatus)
  155. Type Frequency and Antimicrobial Susceptibility ofMycobacterium avium-intracellulareComplex Strains Isolated in Italy from AIDS and Non-AIDS Patients
  156. Mycobacterium genavense and Mycobacterium avium mixed infection in an AIDS patient
  157. 438-PA11 Multidrug resistant tuberculosis in the province of Florence (Italy)
  158. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium
  159. Utility of high-performance liquid chromatography for identification of mycobacterial species rarely encountered in clinical laboratories
  160. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study
  161. Radiometric Susceptibility Testing ofMycobacterium xenopi
  162. Ciprofloxacin Resistance in Clinical Isolates of Pseudomonas aeruginosa from Italian Patients
  163. Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex
  164. Disseminated infection due to Mycobacterium celatum in patient with AIDS
  165. Evaluation of a commercial DNA probe assay for the identification ofMycobacterium kansasii
  166. Cultural studies on two isolates of “Mycobacterium genavense” from patients with acquired immunodeficiency syndrome
  167. NasalMycobacterium kansasii infection in a patient with acquired immunodeficiency syndrome
  168. Multicentre evaluation of a biphasic culture system for recovery of mycobacteria from clinical specimens
  169. Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study
  170. Mycobacterium xenopi isolation from clinical specimens in the florence area: Review of 46 cases